Trial Profile
An Open-Label, Single-Dose, Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2015
Price :
$35
*
At a glance
- Drugs Ulimorelin (Primary)
- Indications Postoperative ileus
- Focus Pharmacokinetics
- Sponsors Norgine
- 24 Apr 2015 New trial record